Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Sep 3, 2026 · CHIEF ACCOUNTING OFFICER Megna Michael R sold 4,600 Class A Ordinary Share at $80.30/unit ($369.4K); exercised options for 22.99K shares; was granted 18.53K shares at $0.5044/share ($9,347); reported 5,531 Class A Ordinary Share

CHIEF ACCOUNTING OFFICER Megna Michael R sold 4,600 Class A Ordinary Share at $80.30/unit ($369.4K); exercised options for 22.99K shares; was granted 18.53K shares at $0.5044/share ($9,347); reported 5,531 Class A Ordinary Share

Filed: Sep 3, 2026
Period: Jul 15, 2026
Accession: 0001464583-26-000008
Filer: Kiniksa Pharmaceuticals International, plc

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09032026_080913.xml

xslF345X06/form4-09032026_080913.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09032026_080913.xml
Open SEC.gov